Focus on Cancer-logo

Focus on Cancer


ReachMD takes a closer look at the latest advances in cancer research, diagnosis, and treatment.

ReachMD takes a closer look at the latest advances in cancer research, diagnosis, and treatment.
More Information


United States




ReachMD takes a closer look at the latest advances in cancer research, diagnosis, and treatment.




Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines

Host: John J. Russell, MD Guest: Richard Wender, MD From oncologists to primary care, physicians are witnessing an alarming trend in younger patients: the rising risk of colorectal cancer. To investigate this growing threat, Dr. John Russell speaks with Dr. Rich Wender, Chief Cancer Control Officier at the American Cancer Society. Dr. Wender discusses the new colorectal cancer screening guidelines set forth and the methods behind the conclusion. While comparing past guidelines, Dr....


FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. MVASI is the first biosimilar approved in the US for the treatment of cancer. Released on December 21, 2017


CAR-T Therapy: A Breakthrough Tool for Fighting Cancer

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called CAR-T (chimeric antigen receptor T-cell)...


Pancreatic Cancer: The Hunt to Catch a Silent Killer

Host: John J. Russell, MD Guest: Harish Lavu, MD Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. This is due, in large part, to its insidious onset and subtle presentation even at late stages, many symptoms of which are often attributed to common and less serious conditions in aging populations. Dr. Harish Lavu, Head of Hepatopancreatobiliary Surgery at Jefferson University, talks with host Dr. John Russell about the...


FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer. Released July 28, 2017


FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer. Released July 25, 2017


The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing

Host: Kathy King, RDN Guest: Lise Alschuler, ND Host Kathy King sits down with Dr. Lise Alschuler, naturopathic doctor, cancer survivor, and author of The Definitive Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing. Dr. Alschuler is co-founder of, a web application providing personalized wellness plans tailored to cancer survivors. They talk about how integrative medicine specialists approach cancer: its causes, prevention strategies, and...


Linking p53 Variation to Breast Cancer Risk in African American Women

Host: Brian P. McDonough, MD, FAAFP It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, specifically, and how can we leverage these understandings into better primary care? Dr. Brian McDonough is joined by Dr. Maureen Murphy, research scientist at the Wistar Institute at the University of Pennsylvania. Dr. Murphy has spent the past twenty years studying how genes affect breast cancer risk...


FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated. Released May 30, 2017.


The Financial Burden of Cancer: Report from the American Cancer Society

Host: Brian P. McDonough, MD, FAAFP Host Dr. Brian McDonough chats with Jennifer Singleterry, Senior Analyst of Policy and Legislative Support for the American Cancer Society's Cancer Action Network, about the organization's new report revealing monetary burdens for cancer patients.


FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy. Released May 18, 2017


Improving Surveillance for Colorectal Cancer in IBD Patients

Host: Caren Heller, MD Guest: Francis Farraye, MD Studies have shown that certain patients living with inflammatory bowel disease, or IBD, have a higher risk of developing colorectal cancer. In fact, IBD ranks as the third highest risk factor for the development of colorectal cancer. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, sits down with Dr. Francis Farraye, gastroenterologist and Professor of Medicine and Co-Director of the Center for...


HPV Vaccine: A Systematic Review of 10 Years of Real-World Experience

Host: Susan J. Wysocki, WHNP, FAANP Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience Clinical Infectious Disease 16 Aug 15;63(4):519-27. doi: 10.1093/cid/ciw354. Epub 2016 May 26. Garland SM1, Kjaer SK2, Muñoz N3, Block SL4, Brown DR5, DiNubile MJ6, Lindsay BR6, Kuter BJ6, Perez G7, Dominiak-Felden G8, Saah AJ6,Drury R8, Das R6, Velicer C6. Abstract: Prophylactic human papillomavirus (HPV) vaccination...


APMs in Cancer Care: The Patient-Centered Oncology Payment Model

Host: Matt Birnholz, MD Guest: Robin Zon, MD, FACP Value-based, patient-centered care has become the destination for all branches of medicine, and is the philosophy driving modern payment reform initiatives like MACRA. But the unique care delivery needs in each specialty challenge the notion that one payment model can serve everyone. And nowhere has this become more relevant than in the field of oncology. Dr. Matt Birnholz joins Dr. Robin Zon, practicing oncologist and vice president and...


Cervical Cancer & Co-testing: What is the Economic Impact?

Host: John J. Russell, MD Guest: Michael Randell, MD In this special edition of Advances in Women’s Health, Dr. Michael Randell shares his insights on cervical cancer testing and whether performing two cervical cancer tests is really more expensive than one from both clinical and economic standpoints. Join host Dr. John Russell for this informative discussion. Click here to learn more about other women's health programs in this special series.


New Recommendations for Colorectal Cancer Screening

[Read the Article] The U.S. Preventative Services Task Force has updated the recommendations regarding colorectal cancer screening. The Task Force strongly recommends screening average risk adults age 50 to 75 for colorectal cancer, and then making individual screening decisions for adults age 76 to 85, taking into account the patient's overall health and screening history.Colorectal cancer is the second leading cause of cancer death in the United States, and about one-third of adults in...


How Dietary Choices Can Influence Cancer Outcomes

Host: Kathy King Guest: Diana Noland How can our dietary choices affect and even influence cancer outcomes? Host Kathy King talks with Diana Noland, dietitian and board-certified clinical nutritionist on the adjunct faculty of the University of Kansas Medical Center Department of Dietetics and Nutrition, and in private practice in Burbank, CA. Ms. Noland specializes in nutritional health for complex metabolic conditions, oncology, gastrointestinal, and neurologic chronic diseases. She...


Breast Cancer's Reality Check: Separating Facts from Fiction for Patients

Host: Jennifer Caudle, DO There are many widely circulated myths regarding breast cancer, such as: Beliefs that this disease affects women only. Fears that mammograms can cause cancers to spread. Assumptions that most patients with breast cancer have family histories positive for this disease. Host Jennifer Caudle talks with guest Dr. Monique Gary, a fellowship-trained breast surgical oncologist at Grand View Health in Sellersville, Pennsylvania. Together, they dispel myths about breast...


New Treatment for Advanced Melanoma Shows Promise

[Read the Article] In a new study, researchers from the University of California-Los Angeles studied tumor response and overall survival following the administration of a new treatment among patients with advanced melanoma. This agent, called pembrolizumab, is an antibody that blocks PD-1, a protein which prevents the body's immune system from attacking the cancer.The researchers tested pembrolizumab on more than 650 patients in North America, Europe and Australia. They looked at tumor...


High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management

Host: Matt Birnholz, MD Cannabis is gaining increased acceptance within the medical community for pain relief and other supportive care applications. But for oncology specialties, the use of cannabis may additionally extend into therapeutic purposes for patients. From the floors of the A4M Conference in Las Vegas, Dr. Matt Birnholz speaks with Constance Finley, Founder and CEO of Constance Therapeutics, a California-based cannabis collective. The two discuss cannabis and cannabis oil...